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Abstract
Modern imaging modalities, including magnetic resonance imaging
(MRI), are valuable diagnostic and therapy monitoring tools in
rheumatoid arthritis (RA). This article reviewed how these imaging
modalities have greatly improved our understanding of pathogenic
mechanisms in RA, namely the link between inflammation and
damage. For example, traditional paradigms regarding the mecha-
nisms of joint destruction, including the idea that synovitis and
damage are uncoupled, have been challenged. As the power of
MRI increases, there is a need to define normality since apparently
normal joints occasionally exhibit MRI evidence of synovitis in the
absence of symptoms.
Introduction: a historical perspective
Historically, subjects with rheumatoid arthritis (RA) presented
relatively late for specialist rheumatology assessment
following the failure of anti-inflammatory agents. Patients
were eventually treated with disease-modifying therapies
such as gold and penicillamine, which were of limited efficacy
in comparison with modern therapeutic standards. Taken
together, this delayed presentation and relative inefficacy of
therapies meant that many patients had quite florid joint
destruction at clinical presentation. The gold standard clinical
imaging modality for RA is projection radiography (x-ray), in
which periarticular osteopenia, joint space loss, and marginal
erosion are noted to be commonplace. Of these abnor-
malities, marginal erosions came to be viewed as a specific
and relatively sensitive diagnostic test and were adopted by
the American College of Rheumatology as classification
criteria for RA in 1987 [1].
Projection radiography therefore has placed the marginal
erosive process centre stage in disease and has led to the
idea that joint erosion and synovitis are often uncoupled
(Table 1). This concept emerged because the relationship
between joint swelling and joint destruction was not linear,
since erosion progressed when synovitis was apparently
treated [2-4]. Such clinical observations helped spur cellular
and molecular investigations that revealed that an apparent
uncoupling process was linked to synovial fibroblast
transformation in which such cells were shown to destroy
cartilage in a manner that was autonomous of inflammation
[5]. At the dawn of the era of biological therapy in RA, this
theory led to the concept of a dual-therapeutic strategy,
including anti-inflammatory biological therapy, on one hand,
and antineoplastic type drug strategies, including metallo-
protease inhibition, on the other [6].
Despite the worldwide recognition of projection radiography
as a relatively easily available imaging tool for RA, patients
now present early, at the stage when projection radiography
is normal in the majority of cases. This has driven the need for
alternative imaging modalities for the assessment of early
arthritis. Magnetic resonance imaging (MRI) has been
recognised since the 1980s as a promising imaging tool in
evaluating musculoskeletal disorders [7]. The remainder of
this article deals with how MRI has challenged RA patho-
genic concepts and how this has far-reaching implications.
How magnetic resonance imaging changed
the way we view rheumatoid arthritis
Joint failure is the final common pathway of an array of
inflammatory, crystal, and degenerative arthritis. The advan-
tage of seeing patients early in the course of disease is that
abnormalities evident in imaging are likely to be primary rather
than secondary. Unlike projection radiography (which could
essentially show only bone), MRI has unparalleled tomo-
graphic capabilities and can define different soft tissue struc-
tures within the joint, including the ability to clearly depict
synovitis following the administration of the MRI contrast
agent gadolinium-DTPA (Gd-DTPA) [8]. Ultrasound also
brings with it excellent spatial resolution capabilities and the
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ability to visualise soft tissue and also erosion at quite high
resolution, but unlike MRI, ultrasound is unable to ascertain
pathologies taking place within the bone. Historically, papers
dealing with MRI in rheumatology devoted considerable
space to the technology and methodology because there
were very few relevant data accrued using this modality.
However, since there is now such a wealth of imaging data
available from MRI, the present article will focus on it.
Magnetic resonance imaging determined
bone erosion and bone oedema in
rheumatoid arthritis
The original studies of MRI showed that it is more sensitive
than projection radiography for the detection of erosions,
particularly in the wrist joints [9,10]; however, at the outset, it
was not clear whether radiographic and MRI erosions repre-
sented the same pathological processes. Not surprisingly, the
tomographic nature of MRI has been used to show that
erosions are more commonly detected compared with
radiography at several sites, including the metacarpophalan-
geal (MCP) joints, shoulders, odontoid peg, knee, and feet [11-
16]. Unlike erosion formation in small joints, studies to date
using MRI have not proven to be beneficial for the assessment
of articular cartilage loss in small joint disease in RA [17].
The advent of fat suppression MRI allowed rheumatologists
to appreciate a new joint abnormality that was hitherto
unrecognised in RA, namely periarticular bone oedema.
Unlike erosions, this abnormality can be quite diffuse and may
involve the entire MCP head. The administration of Gd-DTPA
combined with fat suppression sequences strongly
suggested that this represented an inflammatory process or
an osteitis (Figure 1). Indeed, this has been confirmed
histologically by evaluating tissue obtained at small joint
arthroplasty in chronic RA where bone oedema lesions were
identified prior to surgery [18].
In practice, MRI bone erosions may be associated with an
extensive halo of bone oedema. Historically, bone oedema is
seen on fat suppression MRI sequences, but particularly
severe bone oedema in which there has been extensive
replacement of marrow fat may be evident on T1-weighted
sequences. MRI erosion and bone oedema are intimately
linked from the pathophysiological perspective. Bone oedema
may regress following therapy with corticosteroids and
methotrexate or following biological therapy. Hence, the
regression of severe bone oedema lesions (evident even on
T1-weighted imaging) has been taken as evidence for healing
of erosions [19] (Figure 1). Strictly speaking, this is not true
healing; this apparent repair (in reality, the resolution of
inflammation) is in no way the same as healing of
radiographic erosions where frank bone recortication may
occur (Figure 2). These MRI features, in fact, depict the
reversal of a preradiographic abnormality. However, the
natural history of untreated MRI bone oedema is the subse-
quent development of radiographic erosions [20]. It has been
fairly conclusively shown that MRI bone erosions are also
associated with a cortical break as depicted by high-
resolution ultrasound and computerised tomography confir-
ming that they represent the same disease process [21,22].
Synovitis and associated extracapsular
changes in rheumatoid arthritis and other
arthropathies
The ability of MRI to demonstrate synovitis in RA is the
greatest strength of this method over projection radiography.
The presence of synovitis can be inferred best on T2-
weighted sequences based on increased joint fluid and
confirmed using Gd-DTPA, which has greatly improved the
accurate quantification of synovitis. Several studies have
shown that MRI synovitis correlates extremely well with
histological grades of synovitis, including tissue vascularity
[23,24]. A number of approaches to assess synovitis can be
Table 1
Traditional model for rheumatoid arthritis (RA) based mainly on radiographic findings and modern concepts emerging from
magnetic resonance imaging in RA
Traditional paradigms for RA Modern imaging paradigms
Erosions A relatively late feature Present in the majority at clinical presentation
Synovitis and damage Synovitis not necessarily linked to damage – uncoupling Linear link between synovitis with damage
Erosion mechanism Immunologically mediated or autonomously by  Major biomechanical contribution – such factors may 
synovial fibroblasts mechanically uncouple synovitis from damage.
Cutting edge of erosions Synovial fibroblasts and osteoclasts destroy tissue  Recognition that magnetic resonance imaging bone 
from outside in. oedema represents a diffuse osteitis – at least some of 
erosive process occurs within the bone.
Synovitis locations Considered as diffuse Regional variations within and between joints
Pathophysiological  Erosion formation and cartilage pannus junction  Erosion and pannus are inevitable and predictable 
perspective key to understanding RA consequences of chronic synovitis, RA being the most 
common cause.Page 3 of 7
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used, including the quantitative measurement of synovitis by
the evaluation of its thickness in millimetres, calculation of the
volume of a given slice, or estimating the entire joint volume
[25-27]. Alternative qualitative methods have also been used,
including the dynamic measurement of the initial rate of Gd-
DTPA enhancement and maximal enhancement, both of
which are useful surrogates for the degree of synovial
vascularity [28,29]. Generally, there is a correlation between
the severity of synovitis and all of these parameters.
Whilst joint inflammation is conceptualised in relationship to
synovitis in RA, studies have shown that severe synovitis is
Available online http://arthritis-research.com/content/10/5/222
Figure 1
Coronal magnetic resonance imaging (MRI) of the metacarpophalangeal (MCP) joints. (a) T1-weighted image from the MCP joints in early
rheumatoid arthritis, and (b) corresponding fat suppression image at baseline. (c) Corresponding T1-weighted image at 6 months, and (d) fat
suppression image at 6-month follow-up. The diffuse low signal at sites of MRI erosion in (a) (arrows) is better demarcated in (c) (arrowheads). The
osteitis process at the 2nd, 3rd, and 4th MCP heads in (b) (arrows) has either improved or dramatically regressed in (d) (arrowhead). These
images depict the inflammatory component to the MRI erosive process.
Figure 2
Model for understanding the link between radiographic and magnetic resonance imaging (MRI) erosion. (a) A diagrammatic ‘chessboard’ model of
a normal joint. The white squares depict the calcium-containing tissues on radiography. The black squares depict the soft tissues that are ‘invisible’
on radiography but that are visible on MRI due to their hydrogen atom content (fat or water on TI-weighted images and water on fat suppression
images). (b) Radiographic erosion where bone cortex and trabecular bone are lost, hence the x-ray appearance of a ‘hole’ in the bone. Though not
visible on x-ray, the erosion may be filled with stromal tissue. (c) Bone oedema on a fat suppression MRI. In this pre-erosive stage, the bone
trabecular network is invisible to MRI (but is nevertheless present). The marrow soft tissues have an increased water content due to the osteitis that
is seen as a high signal on fat suppression MRI (grey squares), as shown in (b). In the early stages, this will be associated with minimal bone
trabecular destruction since it takes time from the inflammatory insult to end in osteoclast-mediated joint destruction. So the MRI pre-erosion lesion
will not be evident on radiography. Because this is essentially inflammatory tissue, the resultant MRI lesions may appear to shrink or heal following
therapy. Unlike radiographic erosions, this represents regression of inflammation rather than true bone repair. Nevertheless, the consequence of
suppressing MRI erosions is that future radiographic damage may be prevented.associated with extracapsular inflammation which likely
relates to the nonspecific extension of a severe inflammatory
reaction to the immediately adjacent tissues [30]. These
extracapsular changes could be important for abnormalities,
including ulnar drift and digital subluxation, but this needs to
be assessed. Given that extracapsular abnormalities when
present in systemic lupus erythematosus-associated hand
disease are strongly linked to Jaccoud arthropathy, where
disabling digital deviation is the norm, it seems that such
extrasynovial changes are important. Extracapsular inflam-
matory changes are much more common in the spondylo-
arthropathies (SpAs) and polymyalgia rheumatica (PMR)-
associated hand disease, likely reflecting a different epicentre
of the joint disease [31-33]. Also, clinical synovitis in osteo-
arthritis (OA) may be associated with florid extracapsular
changes in small joint hand involvement [34,35]. The implica-
tions of these MRI observations are that clinically evident
synovitis, in fact, may have a prominent nonsynovial compo-
nent. From the practical perspective, this overlap in extra-
capsular soft tissue pathology means that it is not feasible to
use these changes as a diagnostic test in individual cases.
There is evidence that knee joint synovitis in psoriatic arthritis
is more vascular as assessed arthroscopically and histo-
logically compared with RA [36,37]. Again, MRI studies
support this observation at the population level but it is not
suitable as a diagnostic test [38]. However, studies in wrist
and MCP joints have actually shown a more or equally
vascular synovium in RA compared with SpA [39]. From MRI
studies, the concept is emerging that there are certain site-
specific differences in synovitis within and between diseases
and the implications of this need further exploration.
It has been established that the suppression of synovitis in
RA may be associated with some persistent disease at the
histological level [40]. The same appears to hold true for MRI
and ultrasound where synovial thickening may be evident in
apparent clinical remission [41]. Since the synovium appears
to be the primary target for the autoimmune process in
autoantibody-associated RA, a reasonable goal should be its
complete ablation. However, this raises the old question:
where does normal end and disease begin? For example,
some studies have shown that, on MRI, normal joints may
occasionally have a small degree of enhancement [42].
Furthermore, OA may be associated with subclinical
synovitis, and secondary OA is quite common in RA. This
means that, in established disease with secondary damage,
at least a component of the synovitis may not be autoimmune-
driven in origin. Many important issues need addressing here,
including how patients will respond to biological therapies for
secondary degenerative-related synovitis, which could be
erroneously interpreted as representing part of the primary
autoimmune process.
It has also emerged that synovitis in RA, and indeed in other
arthropathies, is not of equal magnitude within joints; for
example, a greater volume of synovitis adjacent to the patella
was found compared with remote sites in the suprapatellar
pouch [38,43]. This could be of considerable consequence
since it is much more difficult to ablate synovitis at this latter
location. Whether this ‘minimal residual synovitis’ is prognos-
tically relevant awaits further assessment.
The relationship between synovitis and bone
erosion in rheumatoid arthritis
Radiographic studies have fuelled the notion that synovitis
and joint erosion could be uncoupled. Our studies showed
that synovitis was primary in RA and that erosions were seen
only in joints where synovitis was present [44]. We subse-
quently demonstrated this in longitudinal studies and noted
that, in patients with persistent synovitis, erosive disease
continued in individual joints but that, where synovitis was
suppressed to a very low level, the erosive process ceased
[26]. An identical scenario was shown by other groups in the
wrist joints [27]. It was also shown that joint erosion
progression in joints without clinical synovitis was related to
subclinical synovitis that could be detected on MRI [41]. In
fact, radiographic progression of joint damage has been
documented in patients who were in clinical remission [4].
However, in support of the theory that synovitis and bone
erosion may be uncoupled are the findings from studies that
show bone oedema to be a much stronger predictor of
erosion than synovitis [20,45,46]. We propose that bone
oedema is secondary to synovitis and consistent with this
hypothesis is the observation that the magnitude of synovitis
measured in a serial fashion is an independent predictor of
MRI bone erosion [26,44]. Overall, MRI studies argue against
the prevailing view that synovitis and erosion were uncoupled
and are linked by an intermediate osteitis that is secondary to
synovitis, and these observations are further appraised below.
Uncoupling of synovitis and erosion—but not
as we know it
In MRI studies, to characterise the nature of erosion in RA, it
was noted that bone erosions have a particular propensity to
occur adjacent to the MCP joint collateral ligaments [47]
(Figure 3). Actually, it had been known for many years, based
on radiographic observation, that erosions were often
‘compressive’ in that they occurred adjacent to the small joint
radial and ulnar collateral ligaments [48]. It is somewhat
paradoxical that MRI does not support the uncoupling of
inflammation from joint destruction concept since the
presence of inflammation appears to be a sine qua non for
erosion, but it does suggest that there is a biomechanical
uncoupling of inflammation from damage. We have noted that
the volume of synovitis in RA may be twice as great in the
dorsal regions of the third MCP joints compared with the
region adjacent to the radial collateral ligament in the fourth
MCP joint, yet erosion formation was much more common in
the latter site [47]. Coincidentally, it happens that these
regions at the margin of the joints are the best visualised on
projection radiography.
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other arthropathies
Radiographic marginal erosions have been well recognised in
other arthropathies, including psoriatic arthritis, and in erosive
hand OA, usually in established or late disease [49,50]. As
stated earlier, erosions have assumed a very important role in
the diagnosis of RA, in predicting prognosis and for
monitoring therapy. The demonstration that MRI erosive
disease was commonplace in early RA fuelled the idea that
erosion was fundamental, not just for diagnosis but also for
understanding disease pathophysiology. Consequently, the
idea has emerged that a scan of a patient with early RA
showing MRI erosions places patients in a worse prognostic
group. Indeed, there is evidence that MRI erosions in early
RA predict subsequent radiographic erosions [19,51].
However, as explained below, the use of MRI for RA
diagnosis based on ‘MRI erosions’ is potentially flawed.
As already stated, an early MRI bone erosion is not identical
to mature radiographic erosion (Figure 2). Few would argue
that PMR-associated hand synovitis is not associated with
radiographic erosion development. However, PMR-
associated hand disease has a similar degree of MRI bone
erosion and bone oedema compared with early RA [31].
Furthermore, in the proof-of-concept study in question, the
PMR group eventually went into complete remission. These
findings underscore that early MRI erosions per se may not
be prognostically relevant. What is the basis for these
observations? It is likely that the dramatic response of PMR
to corticosteroids leads to a dramatic suppression of syno-
vitis and hence the erosive process is halted. Any bone
cortical damage associated with PMR will consequently be
less evident. This contrasts with RA, where synovitis has
persisted despite therapy. These MRI observations are not
confined just to PMR since hand erosive disease in early
psoriatic arthritis that was selected on the basis of enthesitis
pathology showed the same degree of erosion as RA [39].
Finally, a small proportion of hand OA patients have an
erosive phenotype on radiography [49]. However, on high-
resolution MRI, it is apparent that the erosive phenotype is
the norm rather than the exception [34,35].
Conclusion
To date, MRI studies appear to confirm that autoantibody-
associated RA is primarily a disorder of synovium. This
emphasises the importance of the effective treatment of
synovitis as being the only necessary and sufficient thera-
peutic goal for RA. It is clear that erosive disease is
secondary and a predictable consequence of synovitis, with
the added caveat that sites of joint compression may be more
prone to erosion (Figure 3). However, we feel that the erosion
concept and the link with poorer prognosis are so firmly
engrained in the rheumatology community that MRI will be
used erroneously for quite some time as a diagnostic or
prognostic test for early RA. Also, MRI technology is
advancing at a steady rate with improved resolution and an
increasing emergent platform for undertaking molecular
imaging in vivo in humans. The power of imaging to probe
beyond the anatomical basis for RA and progressively delve
Available online http://arthritis-research.com/content/10/5/222
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Figure 3
Proposed series of events leading to bone erosion. The advent of magnetic resonance imaging (MRI) in early rheumatoid arthritis (RA) allows the
demonstration of the early appearance of MRI bone oedema, histologically an osteitis, suggesting that the path to bone destruction in RA should
be viewed as a close integration of synovitis and erosion. Modifying factors such as the position of joint collateral ligaments, the degree of synovitis,
and bone mineral density may modify erosion formation.
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